Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Kong (Portsmouth, United Kingdom), O. Adeagbo (Portsmouth, United Kingdom), R. Hooper (Portsmouth, United Kingdom), V. Titmuss (Portsmouth, United Kingdom), S. Babu (Portsmouth, United Kingdom). Usefulness of pulsed cyclophosphamide in Interstitial Lung Disease (ILD). 2982

Member's Comments

No comment yet.

Related content which might interest you: Inmunosuppresor therapy effectivness in Interstitial Lung Disease (ILD) associated Connective Tisuue Disease(CTD). Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Usefulness of electronic nose in detection of Interstitial Lung Diseases (ILD) Source: International Congress 2019 – Biomarkers and beyond in idiopathic interstitial pneumonia Year: 2019 Interstitial Lung Disease (ILD) in aluminium welders Source: Virtual Congress 2020 – Occupational and environmental causes of respiratory disease Year: 2020 Unclassifiable Interstitial Lung Disease (ILD). Why? Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Assessment of Treatment Response in Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019 Benefit of steroid-free treatment compared to standard therapy (ST) in pulmonary sarcoidosis Source: International Congress 2014 – ILDs 5 Year: 2014 Combined pulmonary fibrosis and emphysema: A report from the Hellenic Interstitial Lung Diseases group Source: Annual Congress 2010 - Different patterns of interstitial lung disease Year: 2010 Gender perspective in Interstitial Lung Diseases (ILD) Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment Year: 2019 Pulmonary function changes during treatment with rituximab in patients with rheumatoid arthritis Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 The incidence of Progressive Fibrotic Interstitial Lung Diseases (PFILD) treatable with oral-antifibrotic therapy in a UK Specialist Interstitial Lung Disease clinic. Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 Value of community based Pulmonary Rehabilitation (PR) for patients with Interstitial Lung Disease (ILD): A retrospective review Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Treatment of IPF with inhaled IFN-gamma; planning for a clinical trial Source: International Congress 2014 – ILDs 3 Year: 2014 LATE-BREAKING ABSTRACT: Efficacy of Pirfenidone for Idiopathic Pulmonary Fibrosis (IPF): an Italian real life study Source: International Congress 2014 – IPF and surroundings Year: 2014 Utility of Lung Ultrasound in Interstitial Lung Disease - A Paradigm Shift Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause Year: 2020 Tracking crackles of Interstitial Lung Disease during sleep. Source: International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems Year: 2018 Clinical effect of pirfenidone on incidence of lung carcinoma in chronic interstitial pneumonia Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Hypersentivity pneumonitis in an Interstitial Lung Disease Unit, 5 years’ experience Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause Year: 2020 A Comparison of Pulmonary Rehabilitation Outcomes in Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 Transbronchial Lung Cryobiopsy (TBLC) for Interstitial Lung Disease (ILD) can be safely done in patients with multiple medical comorbidities Source: Virtual Congress 2020 – Interventional pulmonology: unity in diversity Year: 2020 Predictive Findings of Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021